Patents by Inventor Yong Deog Hong

Yong Deog Hong has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210145853
    Abstract: The present specification relates to an anti-inflammatory composition including a novel quercetin-based compound isolated from a post-fermented tea, an isomer thereof, a pharmaceutically acceptable salt thereof, a hydrate thereof, or a solvate thereof, and may be widely used in various areas related to anti-inflammation.
    Type: Application
    Filed: June 11, 2018
    Publication date: May 20, 2021
    Applicant: AMOREPACIFIC CORPORATION
    Inventors: Yong-Deog HONG, Jeong-Kee KIM
  • Patent number: 11000537
    Abstract: The present specification relates to a composition containing novel ginsenoside, (20S,24R)-6-O-?-D-glucopyranosyl(1?2)-?-D-glucopyranoside-dammar-3-one-20,24-epoxy-6a,12b,25-triol, a pharmaceutically acceptable salt thereof, a hydrate or a solvate thereof as an active ingredient. The composition exhibits excellent effects in glycemic control, lipid metabolic control, cholesterol control, anti-obesity and blood circulation improvement.
    Type: Grant
    Filed: October 17, 2019
    Date of Patent: May 11, 2021
    Assignee: AMOREPACIFIC CORPORATION
    Inventors: Yong Deog Hong, Hyun Woo Jeong
  • Patent number: 11000538
    Abstract: The present specification relates to a composition containing novel (20S,24R)-6-O-?-D-glucopyranosyl(1?2)-?-D-glucopyranoside-dammar-3-one-20,24-epoxy-6a,12b,25-triol, a pharmaceutically acceptable salt thereof, a hydrate or a solvate thereof as an active ingredient. The composition exhibits an excellent exercise ability enhancing effect and anti-fatigue effect.
    Type: Grant
    Filed: October 29, 2019
    Date of Patent: May 11, 2021
    Assignee: AMOREPACIFIC CORPORATION
    Inventors: Yong Deog Hong, Hyun Woo Jeong
  • Publication number: 20210093651
    Abstract: The present disclosure relates to a composition comprising (20S,24R)-6-O-?-D-glucopyranosyl(1?2)-?-D-glucopyranoside-dammar-3-one-20,24-epoxy-6a,12b,25-triol, which is a novel ginsenoside, a pharmaceutically acceptable salt thereof, a hydrate thereof or a solvate thereof as an active ingredient. In addition, it relates to a method for improving skin elasticity or skin wrinkles, which comprises administering an effective amount of (20S,24R)-6-O-?-D-glucopyranosyl(1?2)-?-D-glucopyranoside-dammar-3-one-20,24-epoxy-6a,12b,25-triol, a pharmaceutically acceptable salt thereof, a hydrate thereof or a solvate thereof to a subject in need thereof. The novel ginsenoside, a pharmaceutically acceptable salt thereof, a hydrate thereof or a solvate thereof has a superior effect of improving skin elasticity and skin wrinkles.
    Type: Application
    Filed: September 24, 2020
    Publication date: April 1, 2021
    Applicant: AMOREPACIFIC CORPORATION
    Inventors: Yong Deog HONG, Hyun Woo JEONG
  • Publication number: 20210093653
    Abstract: The present disclosure relates to a composition comprising (20S,24R)-6-O-?-D-glucopyranosyl(1?2)-?-D-glucopyranoside-dammar-3-one-20,24-epoxy-6a,12b,25-triol, which is a novel ginsenoside, a pharmaceutically acceptable salt thereof, a hydrate thereof or a solvate thereof as an active ingredient. In addition, it relates to a method for preventing or improving menopausal symptoms, which comprises administering an effective amount of (20S,24R)-6-O-?-D-glucopyranosyl(1?2)-?-D-glucopyranoside-dammar-3-one-20,24-epoxy-6a,12b,25-triol, a pharmaceutically acceptable salt thereof, a hydrate thereof or a solvate thereof to a subject in need thereof. The novel ginsenoside has a superior effect of preventing or improving menopausal symptoms with a low risk of breast cancer.
    Type: Application
    Filed: September 24, 2020
    Publication date: April 1, 2021
    Applicant: AMOREPACIFIC CORPORATION
    Inventors: Yong Deog HONG, Hyun Woo JEONG
  • Publication number: 20210051972
    Abstract: Disclosed are a particulate processed product of tea and a method for preparing the same. The particulate processed product of tea has a sphericity S10 value of a particle corresponding to 10% cumulative subdistribution in cumulative distribution measured for the sphericity of tea particles of 0.68 or greater. The processed product of tea is convenient to drink because it is readily wetted and dispersed in water. In addition, it can be easily packaged and used due to a low angle of repose and thus excellent flowability.
    Type: Application
    Filed: August 19, 2020
    Publication date: February 25, 2021
    Applicant: AMOREPACIFIC CORPORATION
    Inventors: Kwanghyun SHIN, Wonkyung CHO, Jinoh CHUNG, Yong Deog HONG
  • Patent number: 10881599
    Abstract: The present specification relates to a whitening composition including a novel compound isolated from a post-fermented tea, an isomer thereof, a pharmaceutically acceptable salt thereof, a hydrate thereof, or a solvate thereof, and may be widely used in various areas related to skin whitening and skin care.
    Type: Grant
    Filed: June 11, 2018
    Date of Patent: January 5, 2021
    Assignee: AMOREPACIFIC CORPORATION
    Inventors: Yong-Deog Hong, Jeong-Kee Kim
  • Patent number: 10882882
    Abstract: The present specification relates to a novel compound separated from post fermented tea, an isomer thereof, a pharmaceutically acceptable salt thereof, a hydrate thereof, or a solvate thereof, the compound being capable of being widely used in post fermented tea-related industries and various fields in which the compound may be used.
    Type: Grant
    Filed: October 12, 2017
    Date of Patent: January 5, 2021
    Assignee: AMOREPACIFIC CORPORATION
    Inventors: Yong-Deog Hong, Minsik Choi, Si Young Cho, Jeong-Kee Kim
  • Publication number: 20200397746
    Abstract: The present disclosure relates to a composition for ameliorating a circulatory system disease, which contains a green tea extract with modified ingredient content. According to the present disclosure, it is possible to effectively prevent, ameliorate and treat circulatory system diseases without side effects and, thereby, to greatly help patients with circulatory system diseases and contribute to the development of related industries.
    Type: Application
    Filed: October 8, 2018
    Publication date: December 24, 2020
    Applicant: Amorepacific Corporation
    Inventors: Yeonsu JEONG, Yong-Deog HONG, Jeong-Kee KIM
  • Patent number: 10835470
    Abstract: The present invention relates to a cosmetic composition comprising a compound represented by Formula 1 below as an active ingredient. in the above Formula 1, R1 is -glc(2-1)glc, R2 is -glc, or R1 is -glc, R2 is -glc(6-1)ara(pyr).
    Type: Grant
    Filed: October 26, 2016
    Date of Patent: November 17, 2020
    Assignee: AMOREPACIFIC CORPORATION
    Inventors: Gi Baeg Nam, Dong Hyun Kim, Yong Deog Hong, Cheng Yi Zhang, Jun Seong Park
  • Publication number: 20200323942
    Abstract: The present specification relates to a composition containing a tea extract with an increased specific ingredient content for prevention or alleviation of lipid metabolism disorders. The use of a preparation method and a composition according to the present specification can effectively prevent and treat lipid metabolism disorders including obesity without side effects, thereby meeting related demands and promoting the development of corresponding industries.
    Type: Application
    Filed: August 9, 2018
    Publication date: October 15, 2020
    Applicant: AMOREPACIFIC CORPORATION
    Inventors: Ayoung KIM, Hyun Woo JEONG, Yong-Deog HONG, Jeong-Kee KIM
  • Patent number: 10799551
    Abstract: Disclosed is to provide a composition derived from a natural material and which has an excellent effect of enhancing cognitive function and a method for preparing the same. The extract and composition according to one aspect of the present disclosure are derived from a natural material and thus are safe. It can prevent, ameliorate and treat cognitive decline. Therefore, it allows to improve the quality of life of the elderly population without concerns about side effects and promote development of the related industry.
    Type: Grant
    Filed: August 23, 2018
    Date of Patent: October 13, 2020
    Assignees: AMOREPACIFIC CORPORATION, INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY
    Inventors: Hyungsu Kim, Ayoung Kim, Juewon Kim, Si Young Cho, Yong-Deog Hong, Seung Soo Chung, Suk Jin Ko, Ji Hyun Jeong, Ji Woong Ahn
  • Patent number: 10722442
    Abstract: The present specification relates to a composition containing novel (20S,24R)-6-O-?-D-glucopyranosyl(1?2)-?-D-glucopyranoside-dammar-3-one-20,24-epoxy-6a,12b,25-triol, a pharmaceutically acceptable salt thereof, a hydrate or a solvate thereof as an active ingredient. The composition exhibits an excellent skin brightening effect.
    Type: Grant
    Filed: October 17, 2019
    Date of Patent: July 28, 2020
    Assignee: AMOREPACIFIC CORPORATION
    Inventors: Yong Deog Hong, Hyun Woo Jeong
  • Patent number: 10696611
    Abstract: Disclosed is a novel adamantine derivative compound, an isomer thereof, pharmaceutically acceptable salt thereof, prodrug thereof, hydrate thereof or a solvate thereof. Also disclosed is a method for preparing a novel adamantine derivative compound, an isomer thereof, pharmaceutically acceptable salt thereof, prodrug thereof, hydrate thereof or a solvate thereof. The novel adamantane derivative compound or the like has an excellent anti-androgenic effect.
    Type: Grant
    Filed: August 24, 2015
    Date of Patent: June 30, 2020
    Assignee: AMOREPACIFIC CORPORATION
    Inventors: Yung Hyup Joo, Song Seok Shin, Byoung Young Woo, Heung Soo Baek, Yong Deog Hong, Hong-Ju Shin, Yeon Su Jeong, Jon Hwan Lee
  • Publication number: 20200179259
    Abstract: The present specification relates to a whitening composition including a novel compound isolated from a post-fermented tea, an isomer thereof, a pharmaceutically acceptable salt thereof, a hydrate thereof, or a solvate thereof, and may be widely used in various areas related to skin whitening and skin care.
    Type: Application
    Filed: June 11, 2018
    Publication date: June 11, 2020
    Applicant: AMOREPACIFIC CORPORATION
    Inventors: Yong-Deog HONG, Jeong-Kee KIM
  • Publication number: 20200140474
    Abstract: The present specification relates to a whitening composition containing a novel quercetin-based compound isolated from post-fermented tea, an isomer thereof, a pharmaceutically acceptable salt thereof, a hydrate thereof, or a solvate thereof, wherein the whitening composition can be widely utilized in fields associated with skin whitening and skin care.
    Type: Application
    Filed: June 11, 2018
    Publication date: May 7, 2020
    Applicant: AMOREPACIFIC CORPORATION
    Inventors: Yong-Deog HONG, Jeong-Kee KIM
  • Publication number: 20200128843
    Abstract: The present disclosure discloses a particulate processed product of tea with quick dispersibility in water and a method for manufacturing a particulate processed product of tea. The processed product of tea comprises 20% by weight or less of fine powders having a particle diameter of 75 ?m or less based on the total weight of the tea particles. The manufacturing method comprises the step of manufacturing tea particles using a fluid-bed rotor granulator comprising a rotor disc. The processed product of tea has quick wettability and dispersibility in water and thus is easy to drink. Also, the processed product of tea has a low angle of repose and thus has excellent flowability, so that it is easy to pack and use.
    Type: Application
    Filed: October 25, 2019
    Publication date: April 30, 2020
    Applicant: AMOREPACIFIC CORPORATION
    Inventors: Kwanghyun SHIN, Wonkyung CHO, Jinoh CHUNG, Yong Deog HONG
  • Publication number: 20200131222
    Abstract: The present specification relates to a composition containing novel (20S,24R)-6-O-?-D-glucopyranosyl(1->2)-?-D-glucopyranoside-dammar-3-one-20,24-epoxy-6a,12b,25-triol, a pharmaceutically acceptable salt thereof, a hydrate or a solvate thereof as an active ingredient. The composition exhibits an excellent exercise ability enhancing effect and anti-fatigue effect.
    Type: Application
    Filed: October 29, 2019
    Publication date: April 30, 2020
    Applicant: AMOREPACIFIC CORPORATION
    Inventors: Yong Deog HONG, Hyun Woo JEONG
  • Publication number: 20200121580
    Abstract: The present specification relates to a composition containing novel (20S,24R)-6-O-?-D-glucopyranosyl(1?2)-?-D-glucopyranoside-dammar-3-one-20,24-epoxy-6a,12b,25-triol, a pharmaceutically acceptable salt thereof, a hydrate or a solvate thereof as an active ingredient. The composition exhibits an excellent skin brightening effect.
    Type: Application
    Filed: October 17, 2019
    Publication date: April 23, 2020
    Applicant: AMOREPACIFIC CORPORATION
    Inventors: Yong Deog HONG, Hyun Woo JEONG
  • Publication number: 20200123194
    Abstract: The present specification relates to a composition containing novel ginsenoside, (20S,24R)-6-O-?-D-glucopyranosyl(1->2)-?-D-glucopyranoside-dammar-3-one-20,24-epoxy-6a,12b,25-triol, a pharmaceutically acceptable salt thereof, a hydrate or a solvate thereof as an active ingredient. The composition exhibits excellent effects in glycemic control, lipid metabolic control, cholesterol control, anti-obesity and blood circulation improvement.
    Type: Application
    Filed: October 17, 2019
    Publication date: April 23, 2020
    Applicant: AMOREPACIFIC CORPORATION
    Inventors: Yong Deog HONG, Hyun Woo JEONG